Overview:
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analogue, FDA-approved for the treatment of HIV-associated lipodystrophy. By stimulating natural growth hormone release, it supports fat loss, particularly in the abdominal region, while also promoting lean muscle maintenance and metabolic health.
Primary Benefits:
Reduces visceral (abdominal) fat
Supports lean muscle preservation
Improves lipid metabolism and insulin sensitivity
May enhance cognitive function and sleep quality through GH pathways
Stimulates natural GH release without replacing it directly
Notes:
FDA-approved for a specific indication, but often studied for broader metabolic and body composition uses
Administered via subcutaneous injection
Research continues on applications in longevity and age-related fat redistribution
Tesamorelin
Due to the nature of the products, no returns or exchanges can be accepted.